November 2023

The paper reveals how experiences of ongoing trauma and loss harmed young men’s ties to kinship systems and family and in doing so deprived them of the very systems needed to sustain a sense of value, purpose and belonging.

November 2023

In recent years, much of the focus of the media has been on drugs such as methamphetamine, cocaine, and MDMA (‘ecstasy’).

November 2023

The National Naloxone Reference Group has played a key role in the development of take-home naloxone programs, policy and practice in Australia.

September 2023

Concerns that take-home naloxone (THN) training may lead to riskier drug use, as a form of overdose risk compensation, remain a substantial barrier to training implementation.

June 2023

In October 2018, the Northern Territory government introduced a minimum unit price (MUP) for alcohol of $1.30 per standard drink.

June 2023

Non-prescribed use of pharmaceutical stimulants, such as Ritalin or dexamphetamine, for cognitive or physical enhancement and recreation is a growing concern in Australia and internationally.

June 2023

This study aimed to examine buprenorphine compared with methadone in the treatment of opioid dependence across a wide range of primary and secondary outcomes.

June 2023

This bulletin examines health (mental and physical) and health service access among two samples of people who use illicit drugs: people who inject drugs, and people who use ecstasy and/or other illicit stimulants.

April 2023

This study aimed to determine the comparative effectiveness of postdischarge use of varenicline versus prescription nicotine replacement therapy (NRT) patches for the prevention of recurrent cardiovascular events and mortality.

Pages